triiodothyronine has been researched along with pamidronate in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Greenspan, SL; Maitland, LA; Middlebrooks, VL; Moses, AC; Rosen, HN; Rosenblatt, M; Sullivan, EK | 1 |
Clemens, JD; Dresner-Pollak, R; Greenspan, SL; Moses, AC; Rosen, HN; Rosenblatt, M; Zeind, AJ | 1 |
Dresner-Pollak, R; Greenspan, SL; Gundberg, C; Hock, JM; Maitland, LA; Middlebrooks, VL; Moses, AC; Rosen, HN; Sullivan, EK; Zeind, AJ | 1 |
Chen, T; Greenspan, SL; Gundberg, C; Holick, M; Kung, VT; Moses, AC; Rosen, HN; Seyedin, SM | 1 |
1 review(s) available for triiodothyronine and pamidronate
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for triiodothyronine and pamidronate
Article | Year |
---|---|
Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.
Topics: Adolescent; Adult; Amino Acids; Analysis of Variance; Biomarkers; Bone Resorption; Calcium; Collagen; Collagen Type I; Creatinine; Diphosphonates; Humans; Hydroxyproline; Male; Pamidronate; Peptides; Thyrotropin; Triiodothyronine | 1994 |
Therapy with parenteral pamidronate prevents thyroid hormone-induced bone turnover in humans.
Topics: Adolescent; Adult; Amino Acids; Bone Resorption; Calcitriol; Calcium; Creatinine; Diphosphonates; Humans; Hydroxyproline; Infusions, Intravenous; Male; Osteocalcin; Pamidronate; Parathyroid Hormone; Triiodothyronine | 1993 |
5 other study(ies) available for triiodothyronine and pamidronate
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Subregion analysis of the rat femur: a sensitive indicator of changes in bone density following treatment with thyroid hormone or bisphosphonates.
Topics: Absorptiometry, Photon; Animals; Bone Density; Diphosphonates; Femur; Hyperthyroidism; Male; Minerals; Pamidronate; Rats; Rats, Sprague-Dawley; Thyroid Hormones; Triiodothyronine | 1994 |
Parenteral pamidronate prevents thyroid hormone-induced bone loss in rats.
Topics: Absorptiometry, Photon; Alkaline Phosphatase; Animals; Body Weight; Bone Density; Bone Resorption; Calcium; Diphosphonates; Femur; Hyperthyroidism; Male; Osteocalcin; Pamidronate; Rats; Rats, Sprague-Dawley; Spinal Cord; Triiodothyronine | 1993 |